Takeda Pharmaceutical (TAK) Gains from Sales and Divestitures (2018 - 2026)
Takeda Pharmaceutical (TAK) posted Gains from Sales and Divestitures of $1.22 million for the quarter ended Jun 30, 2026, down 69.8% from $4.04 million a year earlier and down 89.4% from the prior quarter.
Takeda Pharmaceutical (TAK) Gains from Sales and Divestitures (2018 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Gains from Sales and Divestitures at Takeda Pharmaceutical was $17.24 million, down 13.3% year-over-year; for the year ended Mar 31, 2026, it came in at $20.38 million, down 30.9% from the prior year.
- In prior years, Takeda Pharmaceutical's Gains from Sales and Divestitures was $29.51 million in the year ended Mar 31, 2025 (-29.7%), $41.97 million in the year ended Mar 31, 2024, $74,022 in the year ended Mar 31, 2023 (-98.7%) and $5.83 million in the year ended Mar 31, 2022.
- The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly Gains from Sales and Divestitures since the quarter ended Sep 30, 2023.
- On a year-over-year basis, Gains from Sales and Divestitures increased in 1 of the last seven quarters, with an average decline of 42.8%.
- The strongest year-over-year quarter for Gains from Sales and Divestitures in the past five years was the quarter ended Jun 30, 2024, with growth of 463.9%; the weakest was the quarter ended Jun 30, 2025, with a decline of 69.9%.
- According to Business Quant data, Gains from Sales and Divestitures for the three prior quarters was $11.44 million (quarter ended Mar 31, 2026), $2.33 million (quarter ended Dec 31, 2025) and $2.25 million (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Takeda Pharmaceutical | 2.58 Bn | -23.92 Bn | 5.10 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.22 Mn |
| Mar 31, 2026 | 11.44 Mn |
| Dec 31, 2025 | 2.33 Mn |
| Sep 30, 2025 | 2.25 Mn |
| Jun 30, 2025 | 4.04 Mn |
| Mar 31, 2025 | 9.41 Mn |
| Dec 31, 2024 | 3.96 Mn |
| Sep 30, 2024 | 2.47 Mn |
| Jun 30, 2024 | 13.41 Mn |
| Mar 31, 2024 | 27.42 Mn |
| Dec 31, 2023 | 11.39 Mn |
| Sep 30, 2023 | -152,337.35 |
| Jun 30, 2023 | 2.38 Mn |
| Mar 31, 2023 | 1.29 Mn |
| Dec 31, 2022 | -2.17 Mn |
| Sep 30, 2022 | 999,194.37 |
| Jun 30, 2022 | 54,126.69 |
| Jun 30, 2021 | 858,691.71 |
| Mar 31, 2021 | 12.53 Mn |
| Jun 30, 2020 | 2.79 Mn |
Takeda Pharmaceutical Gains from Sales and Divestitures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gains-from-sales-and-divestitures", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();